1. Exela recalls Sodium Bicarbonate Injection vials due to breakages

   News item 29 October 2022 Pages: 1 - 1

2. Labetolol-related nipple pain, Raynaud's syndrome of the nipple

   News item 29 October 2022 Pages: 2 - 2

3. Nurofen Plus: risk of severe hypokalaemia and renal tubular acidosis

   News item 29 October 2022 Pages: 3 - 3

4. Pyridoxine-related peripheral neuropathy

   News item 29 October 2022 Pages: 4 - 4

5. Risk of COVID-19 vaccine-related tinnitus

   News item 29 October 2022 Pages: 5 - 5

6. Sanofi UK recalls batches of teicoplanin due to bacterial endotoxins

   News item 29 October 2022 Pages: 6 - 6

7. AEs in children after Pfizer-BioNTech COVID-19 vaccine

   Clinical study 29 October 2022 Pages: 7 - 7

8. Drugs associated with microscopic colitis in Japanese patients

   Clinical study 29 October 2022 Pages: 8 - 8

9. ICI-related irAEs associated with improved survival

   Clinical study 29 October 2022 Pages: 9 - 9

10. Risk factors for severe irAEs after first-line pembrolizumab

    Clinical study 29 October 2022 Pages: 10 - 10

11. Safety of BNT162b2 COVID-19 vaccine comparable to that of other approved vaccines in young children

    Clinical study 29 October 2022 Pages: 11 - 11

12. Other adverse reaction research

    News item 29 October 2022 Pages: 12 - 12

13. Abatacept/ofatumumab/rituximab

    Case report 29 October 2022 Pages: 13 - 13

14. Acetazolamide/corticosteroids

    Case report 29 October 2022 Pages: 14 - 14

15. Ad26.COV2-S

    Case report 29 October 2022 Pages: 15 - 15

16. Ad26.cov2-s/AZD-1222/metformin

    Case report 29 October 2022 Pages: 16 - 16

17. ad26.COV2-S/immune-globulin/steroids

    Case report 29 October 2022 Pages: 17 - 17

18. Adalimumab

    Case report 29 October 2022 Pages: 18 - 18

19. Adalimumab

    Case report 29 October 2022 Pages: 19 - 19

20. Adalimumab/paracetamol/valproic acid

    Case report 29 October 2022 Pages: 20 - 20

21. Agomelatine/aripiprazole/brexpiprazole/esketamine/ketamine/mirtazapine/vortioxetine

    Case report 29 October 2022 Pages: 21 - 21

22. Albendazole

    Case report 29 October 2022 Pages: 22 - 22

23. Albumin human/meropenem

    Case report 29 October 2022 Pages: 23 - 23

24. Alectinib/ceritinib/etoposide

    Case report 29 October 2022 Pages: 24 - 24

25. Alemtuzumab

    Case report 29 October 2022 Pages: 25 - 25

26. Alemtuzumab/cladribine

    Case report 29 October 2022 Pages: 26 - 27

27. Alendronic-acid

    Case report 29 October 2022 Pages: 27 - 27

28. Allopurinol/azathioprine interaction

    Case report 29 October 2022 Pages: 28 - 28

29. Amantadine/levodopa

    Case report 29 October 2022 Pages: 29 - 29

30. Amfetamine overdose

    Case report 29 October 2022 Pages: 30 - 30

31. Amikacin/levofloxacin

    Case report 29 October 2022 Pages: 31 - 31

32. Amiodarone

    Case report 29 October 2022 Pages: 32 - 32

33. Amiodarone

    Case report 29 October 2022 Pages: 33 - 33

34. Amiodarone

    Case report 29 October 2022 Pages: 34 - 34

35. Amiodarone

    Case report 29 October 2022 Pages: 35 - 35

36. Amitriptyline/levetiracetam/propofol

    Case report 29 October 2022 Pages: 36 - 36

37. Amlodipine/brotizolam/levetiracetam/telmisartan

    Case report 29 October 2022 Pages: 37 - 37

38. Amlodipine/verapamil overdose

    Case report 29 October 2022 Pages: 38 - 38

39. Amphotericin B liposomal

    Case report 29 October 2022 Pages: 39 - 39

40. Amphotericin-B

    Case report 29 October 2022 Pages: 40 - 40

41. Amphotericin-B/fluconazole

    Case report 29 October 2022 Pages: 41 - 41

42. Ampicillin/cefotaxime/gentamicin

    Case report 29 October 2022 Pages: 42 - 42

43. Anakinra/prednisone

    Case report 29 October 2022 Pages: 43 - 43

44. Anti-inflammatories and antineoplastics

    Case report 29 October 2022 Pages: 44 - 44

45. Anti-inflammatories/cyclophosphamide

    Case report 29 October 2022 Pages: 45 - 45

46. Antibacterials

    Case report 29 October 2022 Pages: 46 - 46

47. Antibacterials

    Case report 29 October 2022 Pages: 47 - 47

48. Antibacterials

    Case report 29 October 2022 Pages: 48 - 48

49. Antibacterials/antifungals

    Case report 29 October 2022 Pages: 49 - 49

50. Antibacterials/antituberculars

    Case report 29 October 2022 Pages: 50 - 50